11-118894372-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001716.5(CXCR5):c.828C>T(p.His276His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00167 in 1,614,202 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0086 ( 13 hom., cov: 32)
Exomes 𝑓: 0.00095 ( 15 hom. )
Consequence
CXCR5
NM_001716.5 synonymous
NM_001716.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0440
Genes affected
CXCR5 (HGNC:1060): (C-X-C motif chemokine receptor 5) This gene encodes a multi-pass membrane protein that belongs to the CXC chemokine receptor family. It is expressed in mature B-cells and Burkitt's lymphoma. This cytokine receptor binds to B-lymphocyte chemoattractant (BLC), and is involved in B-cell migration into B-cell follicles of spleen and Peyer patches. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011]
BCL9L (HGNC:23688): (BCL9 like) Enables beta-catenin binding activity. Involved in several processes, including negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of epithelial to mesenchymal transition; and positive regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. Part of beta-catenin-TCF complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 11-118894372-C-T is Benign according to our data. Variant chr11-118894372-C-T is described in ClinVar as [Benign]. Clinvar id is 784217.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.044 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00863 (1314/152332) while in subpopulation AFR AF = 0.0298 (1237/41568). AF 95% confidence interval is 0.0284. There are 13 homozygotes in GnomAd4. There are 601 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 1314 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00859 AC: 1307AN: 152214Hom.: 13 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1307
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00214 AC: 538AN: 251020 AF XY: 0.00144 show subpopulations
GnomAD2 exomes
AF:
AC:
538
AN:
251020
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000948 AC: 1386AN: 1461870Hom.: 15 Cov.: 31 AF XY: 0.000777 AC XY: 565AN XY: 727240 show subpopulations
GnomAD4 exome
AF:
AC:
1386
AN:
1461870
Hom.:
Cov.:
31
AF XY:
AC XY:
565
AN XY:
727240
Gnomad4 AFR exome
AF:
AC:
1035
AN:
33480
Gnomad4 AMR exome
AF:
AC:
76
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26136
Gnomad4 EAS exome
AF:
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
AC:
3
AN:
86258
Gnomad4 FIN exome
AF:
AC:
0
AN:
53402
Gnomad4 NFE exome
AF:
AC:
140
AN:
1112006
Gnomad4 Remaining exome
AF:
AC:
125
AN:
60396
Heterozygous variant carriers
0
92
183
275
366
458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00863 AC: 1314AN: 152332Hom.: 13 Cov.: 32 AF XY: 0.00807 AC XY: 601AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
1314
AN:
152332
Hom.:
Cov.:
32
AF XY:
AC XY:
601
AN XY:
74494
Gnomad4 AFR
AF:
AC:
0.0297585
AN:
0.0297585
Gnomad4 AMR
AF:
AC:
0.00287431
AN:
0.00287431
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000191103
AN:
0.000191103
Gnomad4 OTH
AF:
AC:
0.00946074
AN:
0.00946074
Heterozygous variant carriers
0
65
130
194
259
324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 29, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at